Ilgazlı A - Search Results

1

Prevalence of smoking and chronic obstructive pulmonary disease amongst teachers working in Kocaeli, Turkey.

Barış SA, Yıldız F, Başyiğit I, Boyacı H, Ilgazlı A. Barış SA, et al. Among authors: ilgazli a. Multidiscip Respir Med. 2011 Apr 30;6(2):92-6. doi: 10.1186/2049-6958-6-2-92. Multidiscip Respir Med. 2011. PMID: 22958982 Free PMC article.

2

Inhaled corticosteroids may reduce neutrophilic inflammation in patients with stable chronic obstructive pulmonary disease.

Yildiz F, Kaur AC, Ilgazli A, Celikoglu M, Kaçar Ozkara S, Paksoy N, Ozkarakaş O. Yildiz F, et al. Among authors: ilgazli a. Respiration. 2000;67(1):71-6. doi: 10.1159/000029466. Respiration. 2000. PMID: 10705266 Clinical Trial.

3

The effects of antioxidants on exercise-induced lipid peroxidation in patients with COPD.

Agacdiken A, Basyigit I, Ozden M, Yildiz F, Ural D, Maral H, Boyaci H, Ilgazli A, Komsuoglu B. Agacdiken A, et al. Among authors: ilgazli a. Respirology. 2004 Mar;9(1):38-42. doi: 10.1111/j.1440-1843.2003.00526.x. Respirology. 2004. PMID: 14982600

4

[Diagnostic value of Tc-99m MIBI scintigraphy in the differential diagnosis of malign and benign of intrathoracic pathologies].

Boyaci H, Berk F, Ilgazli A, Erçin C, Yildiz F, Sengül C. Boyaci H, et al. Among authors: ilgazli a. Tuberk Toraks. 2003;51(2):157-62. Tuberk Toraks. 2003. PMID: 15143422 Turkish.

5

The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data.

Basyigit I, Yildiz F, Ozkara SK, Yildirim E, Boyaci H, Ilgazli A. Basyigit I, et al. Among authors: ilgazli a. Ann Pharmacother. 2004 Sep;38(9):1400-5. doi: 10.1345/aph.1D634. Epub 2004 Jul 13. Ann Pharmacother. 2004. PMID: 15252191 Clinical Trial.

6

[Determination of environmental tobacco smoke in primary school children with urine cotinine measurements].

Boyaci H, Duman C, Başyiğit I, Ilgazli A, Yildiz F. Boyaci H, et al. Among authors: ilgazli a. Tuberk Toraks. 2004;52(3):231-6. Tuberk Toraks. 2004. PMID: 15351935 Turkish.

7

[Body mass index and serum and sputum TNF-alpha levels relation in asthma and COPD].

Başyiğit I, Yildiz F, Yildirim E, Boyaci H, Ilgazli A. Başyiğit I, et al. Among authors: ilgazli a. Tuberk Toraks. 2004;52(3):256-61. Tuberk Toraks. 2004. PMID: 15351939 Turkish.

8

Does addition of inhaled steroid to combined bronchodilator therapy affect health status in patients with COPD?

Yildiz F, Basyigit I, Yildirim E, Boyaci H, Ilgazli A. Yildiz F, et al. Among authors: ilgazli a. Respirology. 2004 Aug;9(3):352-5. doi: 10.1111/j.1440-1843.2004.00618.x. Respirology. 2004. PMID: 15363007 Clinical Trial.

9

Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.

Basyigit I, Yildiz F, Ozkara SK, Boyaci H, Ilgazli A. Basyigit I, et al. Among authors: ilgazli a. Mediators Inflamm. 2004 Aug;13(4):285-91. doi: 10.1080/09629350400003118. Mediators Inflamm. 2004. PMID: 15545060 Free PMC article. Clinical Trial.

10

Extrapulmonary tuberculosis: clinical and epidemiologic spectrum of 636 cases.

Ilgazli A, Boyaci H, Basyigit I, Yildiz F. Ilgazli A, et al. Arch Med Res. 2004 Sep-Oct;35(5):435-41. doi: 10.1016/j.arcmed.2004.05.008. Arch Med Res. 2004. PMID: 15610915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters